Respiratory syncytial virus is one of the leading causes of death for infants globally, and a safe vaccine has yet to be approved for use. However, the long search may soon be over, as new structure-based vaccine technology holds great promise.
Subscribe to:
Post Comments (Atom)
< + > A Demo of Truven Health Insights Turning Data Into Actionable Insights
Renee Wiczorek, Lead Product Manager at Truven by Merative , wants healthcare institutions to ask the deep questions about the trends they’...
No comments:
Post a Comment